<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615717</url>
  </required_header>
  <id_info>
    <org_study_id>UNebraskaLincoln</org_study_id>
    <nct_id>NCT02615717</nct_id>
  </id_info>
  <brief_title>Using Attentional Bias Modification to Address Trauma Symptoms</brief_title>
  <official_title>Using Attentional Bias Modification to Address Trauma Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska Lincoln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska Lincoln</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Threat-related attentional biases have been identified as a possible precursor to the onset
      and maintenance of posttraumatic stress disorder (PTSD). As a result, protocols such as
      Attention Bias Modification (ABM) have been developed and utilized to treat these attentional
      biases in adults diagnosed with PTSD. However, to-date, ABM protocols have not been examined
      for use specifically among victims of sexual assaults. Participants are 20 undergraduate
      women enrolled in a Midwest university. The efficacy of ABM in this population will be
      assessed, as will the relationship between ABM and PTSD symptom clusters and outcome
      variables such as anxiety and depression scores.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A relatively new intervention designed to reduce attention toward (or minimize disengagement
      from) threat-related information is attention bias modification (ABM). ABM is a novel
      treatment that may address several limitations posed by the use of CPT and PE. ABM is
      typically administered via computer, involving brief 20-minute sessions in which participants
      are trained to disengage from the threat cues to which they are naturally attuned. ABM
      addresses attentional biases in a similar, though more direct, manner as does CBT through the
      use of uninterrupted, repetitive exposure to feared threat cues or words in order to allow
      the patient to interpret that feared objects and situations are safe. In particular, ABM's
      effectiveness arises through the intent to normalize both attentional biases towards and away
      from threats such that the intended outcome is the non-existence of any bias surrounding
      threat cues. ABM addresses the specific bias in attention through targeting implicit,
      sub-cortical processes that focus on perturbed neural circuitry function. It trains
      individuals to remove any attention to or avoidance of threat cues by training brains to
      focus equally on threat and non-threat cues. Therefore, ABM further extends work implicating
      threat-related attention bias in anxiety disorders.

      ABM has successfully improved or alleviated symptoms of many disorders, including anxiety
      disorders, depression, obsessive-compulsive disorder, and chronic pain. In addition, ABM has
      been successfully implemented in many populations such as inpatient active duty U.S. military
      members, Israeli Defense Force soldiers, pediatrics, and outpatients with chronic PTSD.
      Despite these findings, ABM has never been applied to individuals with current, lifetime, or
      chronic PTSD resulting from sexual assaults. Furthermore, studies assessing the use of ABM
      have found consistent benefits from ABM control groups, although this effect has been smaller
      than those in the ABM treatment groups. Authors contend that the reason that ABM control
      groups may have experienced a decrease in symptoms may be that the use of training
      (regardless of treatment or control status) improves the relationship between emotional
      stimuli and the response required by participants in order to learn to exert attentional
      control.

      If ABM proves to be effective in addressing attentional biases associated with PTSD and its
      associated symptom clusters, it is a unique treatment that has the potential to address many
      of the limitations or concerns faced by those who rely exclusively on CPT or PE; benefits of
      ABM include that the treatment (1) is a relatively simple and brief intervention, (2) may be
      administered electronically and remotely at a patient's home or at locations beyond a typical
      clinical office, and (3) has the potential to be mass-administered. As ABM is a relatively
      new treatment with many implications for utilization, its full potential has not yet been
      explored; in particular, there are several ways with which ABM may interact with empirically
      supported treatments (ESTs) as CPT and PE.

      Firstly, it is important to recognize that CPT and PE have both been criticized for their
      role in requiring participants to immediately &quot;dwell in the past&quot;, frequently resulting in
      clients reporting distress. This is particularly true in individuals who may have potentially
      been coping with or managing their trauma reaction through the use of intense avoidance.
      Thus, as a prelude to integrating individuals into CPT or PE, ABM has the potential to be a
      useful transition prior to ESTs to increase tolerance and prepare individuals to transition
      and integrate into these more provocative types of treatments. Starting with a treatment such
      as ABM, which introduces individuals to non-specific trauma content, might serve to help
      people to be more amenable to other ESTs such as CPT or PE, ultimately increasing willingness
      to start and stay in therapy, decreasing attrition, and improving retention.

      Secondly, ABM interventions have been shown in several populations to result in at least a
      mild reduction of symptoms. Even mild reductions of symptoms may open the door to allowing an
      individual to make larger improvements through more other evidence-based interventions.
      Studies show that individuals with more severe pretreatment trauma-related cognitions have
      slightly worse PE outcomes than do individuals beginning treatment with more moderate
      symptoms. In applying ABM prior to CPT or PE, it is likely that the mild reduction of
      symptoms beforehand may ultimately increase the effectiveness and efficiency of ESTs.

      Current Study Despite recent focus on attention training in PTSD, researchers have not yet
      examined whether training procedures such as ABM are capable of modifying attentional biases
      in individuals whose most disturbing and impactful trauma is a sexual assault. Thus, in this
      current study, the investigators aimed to examine the effect of ABM in a sample of women who
      have previously experienced an adult sexual assault. The aims of this study are three-fold:
      first and foremost, as this is the first study of its kind to assess the efficacy of ABM
      treatment in a sample of sexual assault victims, the investigators will be examining the
      effect of ABM in reducing PTSD symptoms within this trauma type. Secondly, investigators are
      exploring what PTSD symptoms or symptom clusters predict treatment outcomes and attentional
      variability. Finally, investigators expect to quantify and document attention variability in
      this population, and will explore whether variability is predictive of treatment outcomes.

      Regarding this study's aims, investigators hypothesize that (1) both the ABM treatment and
      control groups will experience decreased PTSD, depressive, and anxiety symptoms, but with a
      greater decrease from baseline in the treatment condition. Secondly, investigators
      hypothesize that (2) there will be a relationship between heightened symptom clusters as
      expressed by the individuals and their attentional biases, such that individuals high in
      avoidance symptoms (Criterion C on the Clinician-Administered PTSD Scale, CAPS-5) will
      demonstrate decreased response times to threat cues on measures of executive functioning with
      low variability, while those high in hyperarousal symptoms (Criterion E on the CAPS-5) will
      demonstrate increased response times and low variability. In contrast, investigators expect
      those high in both symptom clusters (hyperarousal and avoidance) will demonstrate high
      variability in reaction times, and those low in both symptom clusters will demonstrate low
      variability. Finally, investigators hypothesize that (3) increased attention variability will
      be associated with higher PTSD, depressive, and anxiety symptoms, but greater changes in
      attention variability across the study will be associated with greater improvements on PTSD,
      depressive, and anxiety symptoms. More specifically, investigators hypothesize that as a
      result of treatment, those participants who have the greatest decreases in variability over
      the course of treatment will be higher in hyperarousal and/or avoidance over those who are
      low in both symptom clusters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinician-Administered PTSD Scale (CAPS-5)</measure>
    <time_frame>within three days</time_frame>
    <description>Assesses symptoms and severity of Posttraumatic Stress Disorder Range: 0-80; total score utilized. Higher values indicate higher severity Subscales are summed to create a total score; subscales made up of different facets of PTSD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PTSD Checklist (PCL-5)</measure>
    <time_frame>within three days</time_frame>
    <description>Self-report of PTSD symptom severity Scale range: 0-80 Total score utilized, all items summed. Higher score indicates higher severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>within three days</time_frame>
    <description>Self-report measure of 9 symptoms related to depression Range: 0-27, all items summed Higher score indicates higher severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory (BAI)</measure>
    <time_frame>within three days</time_frame>
    <description>Self-report measure of 20 symptoms of anxiety Range: 0-60 all items summed Higher score indicates higher severity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Attentional Bias Modification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attentional Control Condition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Bias Modification</intervention_name>
    <description>comparison of treatment versus control</description>
    <arm_group_label>Attentional Bias Modification</arm_group_label>
    <arm_group_label>Attentional Control Condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, 19+, have experienced at least one adult sexual trauma, and must currently be
             experiencing PTSD symptoms as a result of the sexual assault

        Exclusion Criteria:

          -  male
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina L Hein, B.A.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska Lincoln</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska-Lincoln</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aupperle RL, Melrose AJ, Stein MB, Paulus MP. Executive function and PTSD: disengaging from trauma. Neuropharmacology. 2012 Feb;62(2):686-94. doi: 10.1016/j.neuropharm.2011.02.008. Epub 2011 Feb 22. Review.</citation>
    <PMID>21349277</PMID>
  </reference>
  <reference>
    <citation>Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6. Review.</citation>
    <PMID>20456540</PMID>
  </reference>
  <reference>
    <citation>Bar-Haim Y, Holoshitz Y, Eldar S, Frenkel TI, Muller D, Charney DS, Pine DS, Fox NA, Wald I. Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry. 2010 Jun;167(6):694-8. doi: 10.1176/appi.ajp.2009.09070956. Epub 2010 Apr 15.</citation>
    <PMID>20395400</PMID>
  </reference>
  <reference>
    <citation>Carlbring P, Apelstrand M, Sehlin H, Amir N, Rousseau A, Hofmann SG, Andersson G. Internet-delivered attention bias modification training in individuals with social anxiety disorder--a double blind randomized controlled trial. BMC Psychiatry. 2012 Jun 25;12:66. doi: 10.1186/1471-244X-12-66.</citation>
    <PMID>22731889</PMID>
  </reference>
  <reference>
    <citation>Echiverri AM, Jaeger JJ, Chen JA, Moore SA, Zoellner LA. &quot;Dwelling in the Past&quot;: The Role of Rumination in the Treatment of Posttraumatic Stress Disorder. Cogn Behav Pract. 2011 Aug;18(3):338-349.</citation>
    <PMID>22190846</PMID>
  </reference>
  <reference>
    <citation>Eldar S, Apter A, Lotan D, Edgar KP, Naim R, Fox NA, Pine DS, Bar-Haim Y. Attention bias modification treatment for pediatric anxiety disorders: a randomized controlled trial. Am J Psychiatry. 2012 Feb;169(2):213-20.</citation>
    <PMID>22423353</PMID>
  </reference>
  <reference>
    <citation>Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA, Leibenluft E, Ernst M, Pine DS. Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry. 2010 Dec 1;68(11):982-90. doi: 10.1016/j.biopsych.2010.07.021. Erratum in: Biol Psychiatry. 2012 Sep 1;72(5):429.</citation>
    <PMID>20887977</PMID>
  </reference>
  <reference>
    <citation>Iacoviello, B. M., Amir, N., Bar-Haim, Y., Beard, C., Montana, R., Kuckertz, J. W., â€¦ &amp; De Raedt, R. (2014). Maximizing the effects of attention bias modification for anxiety: How and for whom. Symposium presented that the 48th annual congress presented at Associaion for Behavioral and Cognitive Therapies, 21 November 2014.</citation>
  </reference>
  <reference>
    <citation>Kuckertz JM, Amir N, Boffa JW, Warren CK, Rindt SE, Norman S, Ram V, Ziajko L, Webb-Murphy J, McLay R. The effectiveness of an attention bias modification program as an adjunctive treatment for Post-Traumatic Stress Disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. Epub 2014 Sep 16.</citation>
    <PMID>25277496</PMID>
  </reference>
  <reference>
    <citation>Moser JS, Cahill SP, Foa EB. Evidence for poorer outcome in patients with severe negative trauma-related cognitions receiving prolonged exposure plus cognitive restructuring: implications for treatment matching in posttraumatic stress disorder. J Nerv Ment Dis. 2010 Jan;198(1):72-5. doi: 10.1097/NMD.0b013e3181c81fac.</citation>
    <PMID>20061873</PMID>
  </reference>
  <reference>
    <citation>Najmi S, Amir N. The effect of attention training on a behavioral test of contamination fears in individuals with subclinical obsessive-compulsive symptoms. J Abnorm Psychol. 2010 Feb;119(1):136-42. doi: 10.1037/a0017549.</citation>
    <PMID>20141250</PMID>
  </reference>
  <reference>
    <citation>Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. Epub 2012 Dec 22.</citation>
    <PMID>23295710</PMID>
  </reference>
  <reference>
    <citation>Sharpe L, Ianiello M, Dear BF, Nicholson Perry K, Refshauge K, Nicholas MK. Is there a potential role for attention bias modification in pain patients? Results of 2 randomised, controlled trials. Pain. 2012 Mar;153(3):722-31. doi: 10.1016/j.pain.2011.12.014. Epub 2012 Jan 26.</citation>
    <PMID>22281100</PMID>
  </reference>
  <reference>
    <citation>Weathers, F. W., Blake, D. D., Schnurr, P. P., Marx, B. P., &amp; Keane, T. M. (2013). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Interview available from the National Center for PTSD at www.ptsd.va.gov.</citation>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <results_first_submitted>October 17, 2016</results_first_submitted>
  <results_first_submitted_qc>December 8, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 3, 2017</results_first_posted>
  <last_update_submitted>December 8, 2016</last_update_submitted>
  <last_update_submitted_qc>December 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska Lincoln</investigator_affiliation>
    <investigator_full_name>Christina Hein</investigator_full_name>
    <investigator_title>Clinical Psychology Graduate Student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Attentional Bias Modification</title>
          <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
        <group group_id="P2">
          <title>Attentional Control Condition</title>
          <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Attentional Bias Modification</title>
          <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
        <group group_id="B2">
          <title>Attentional Control Condition</title>
          <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.7" spread="1.2"/>
                    <measurement group_id="B2" value="21.7" spread="2.9"/>
                    <measurement group_id="B3" value="20.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinician-Administered PTSD Scale (CAPS-5)</title>
        <description>Assesses symptoms and severity of Posttraumatic Stress Disorder Range: 0-80; total score utilized. Higher values indicate higher severity Subscales are summed to create a total score; subscales made up of different facets of PTSD.</description>
        <time_frame>within three days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attentional Bias Modification</title>
            <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
          <group group_id="O2">
            <title>Attentional Control Condition</title>
            <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
        </group_list>
        <measure>
          <title>Clinician-Administered PTSD Scale (CAPS-5)</title>
          <description>Assesses symptoms and severity of Posttraumatic Stress Disorder Range: 0-80; total score utilized. Higher values indicate higher severity Subscales are summed to create a total score; subscales made up of different facets of PTSD.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.3" spread="10.2"/>
                    <measurement group_id="O2" value="10.0" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PTSD Checklist (PCL-5)</title>
        <description>Self-report of PTSD symptom severity Scale range: 0-80 Total score utilized, all items summed. Higher score indicates higher severity.</description>
        <time_frame>within three days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attentional Bias Modification</title>
            <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
          <group group_id="O2">
            <title>Attentional Control Condition</title>
            <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
        </group_list>
        <measure>
          <title>PTSD Checklist (PCL-5)</title>
          <description>Self-report of PTSD symptom severity Scale range: 0-80 Total score utilized, all items summed. Higher score indicates higher severity.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="8.2"/>
                    <measurement group_id="O2" value="10.0" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Health Questionnaire (PHQ-9)</title>
        <description>Self-report measure of 9 symptoms related to depression Range: 0-27, all items summed Higher score indicates higher severity</description>
        <time_frame>within three days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attentional Bias Modification</title>
            <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
          <group group_id="O2">
            <title>Attentional Control Condition</title>
            <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Health Questionnaire (PHQ-9)</title>
          <description>Self-report measure of 9 symptoms related to depression Range: 0-27, all items summed Higher score indicates higher severity</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="3.8"/>
                    <measurement group_id="O2" value="6.7" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Beck Anxiety Inventory (BAI)</title>
        <description>Self-report measure of 20 symptoms of anxiety Range: 0-60 all items summed Higher score indicates higher severity</description>
        <time_frame>within three days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Attentional Bias Modification</title>
            <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
          <group group_id="O2">
            <title>Attentional Control Condition</title>
            <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
          </group>
        </group_list>
        <measure>
          <title>Beck Anxiety Inventory (BAI)</title>
          <description>Self-report measure of 20 symptoms of anxiety Range: 0-60 all items summed Higher score indicates higher severity</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.0" spread="7.9"/>
                    <measurement group_id="O2" value="29.0" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious and Other (Not Including Serious) Adverse Events were not collected/assessed</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Attentional Bias Modification</title>
          <description>In the ABM treatment condition, participants will have four 20-minute in-lab treatment conditions across two weeks. Within these Attention Bias Modification sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target will always appear in the location of the neutral word).
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
        <group group_id="E2">
          <title>Attentional Control Condition</title>
          <description>Participants will have four 20-minute in-lab treatment conditions across two weeks. Within the Attention Bias Modification control sessions, participants will be presented with a fixation cross for 500 ms. The fixation cross will then be replaced with a word pair consisting of either a threat/neutral pair or a neutral/neutral word for 500 ms, followed by a probe in the location of one of the two words (80% threat/neutral pairs, 20% neutral/neutral pairs; the target appears in the location of the neutral word in 50% of the trials. Complete Stroop and 3-back task, etc.
Attention Bias Modification: comparison of treatment versus control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Christina Hein, M.A.</name_or_title>
      <organization>University of Nebraska, Lincoln</organization>
      <phone>7036184722</phone>
      <email>chein9@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

